BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6857368)

  • 1. [Immunologic status in lung cancer].
    Briusov PG; Polovoĭ AM
    Sov Med; 1983; (3):16-9. PubMed ID: 6857368
    [No Abstract]   [Full Text] [Related]  

  • 2. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors influencing 5-year survival and 6-month mortality after resection of lung cancer].
    Zhang YF; Zhang ZS; Yang M
    Zhonghua Wai Ke Za Zhi; 1987 Oct; 25(10):583-5, 613. PubMed ID: 3449340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological index changes in the surgical treatment of lung cancer].
    Kotliarov EV; Bekhtereva EI; Rask RE; Kriukova LI
    Klin Khir (1962); 1981 Oct; (10):10-2. PubMed ID: 6975852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of immunomodulators in multimodal treatment of patients with lung cancer].
    Vagner VP; Voĭtkevich EG; Zakora GI; Chirvina ED
    Klin Med (Mosk); 1991 Dec; 69(12):55-9. PubMed ID: 1787682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
    Lenzini L; Barnabé R
    Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
    [No Abstract]   [Full Text] [Related]  

  • 9. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of lung cancer].
    Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
    Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
    [No Abstract]   [Full Text] [Related]  

  • 11. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical management of lung cancer].
    Suzuki C
    Gan No Rinsho; 1968 Jan; 14(1):52-6. PubMed ID: 5692163
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A; Skokowski J; Mlekodaj S; Boj E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of primary lung cancer].
    Korolev BA; Karpov MF; Shirokova AP
    Vestn Akad Med Nauk SSSR; 1980; (5):19-23. PubMed ID: 6249053
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in immunoregulatory cells in lung cancer and smoking.
    Ginns LC; Miller LG; Goldenheim PD; Goldstein G; Bria WF
    J Clin Immunol; 1982 Jul; 2(3 Suppl):90S-94S. PubMed ID: 6982280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postoperative prognosis of lung cancer].
    Ishikawa S; Suemasu K; Ogata T; Yoneyama T; Naruke T
    Kyobu Geka; 1969 Jan; 22(1):2-13. PubMed ID: 5813767
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined surgery in cancer of the lung].
    Biriukov IuV; Grigor'eva SP; Ots ON; Partsvaniia NG
    Grudn Khir; 1985; (4):19-22. PubMed ID: 4043806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.